Dimethoxy-dihydroisoquinolin-methyl-triazol-phenylpropyl-oxime
General
Type : Triazol, Isoquinoline, Oxime
Chemical_Nomenclature : N-(3-(4-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyl)-1H-1,2,3-triazol-1-yl)-1-phenylpropyl)-2-(hydroxyimino)acetamide
Canonical SMILES : C1(=C(C=C2C(=C1)CCN(C2)CC4=CN(CCC(C3=CC=CC=C3)NC(C=NO)=O)NN4)OC)OC
InChI : InChI=1S\/C25H32N6O4\/c1-34-23-12-19-8-10-30(15-20(19)13-24(23)35-2)16-21-17-31(29-28-21)11-9-22(27-25(32)14-26-33)18-6-4-3-5-7-18\/h3-7,12-14,17,22,28-29,33H,8-11,15-16H2,1-2H3,(H,27,32)
InChIKey : TVEIRDJHTVTRJT-UHFFFAOYSA-N
Other name(s) :
Target
References (1)
| Title : Structure-guided modification of a lead cholinesterase-targeting oxime to improve peripheral site binding - Marakovic_2026_Arh.Hig.Rada.Toksikol_77_1 |
| Author(s) : Marakovic N , Probst N , Cadez T , Zandona A |
| Ref : Arh Hig Rada Toksikol , 77 :1 , 2026 |
| Abstract : |
| PubMedSearch : Marakovic_2026_Arh.Hig.Rada.Toksikol_77_1 |
| PubMedID: 41944403 |